MS
Mausam Sinha
About Mausam Sinha
Data last updated:
Mausam Sinha is an Additional Director at Willius Pharmaceuticals Private Limited (since 2023) and Additional Director at Biocius Pharmaceuticals Private Limited (since 2023). The companies operate in Food And Beverages and Chemicals. The 2 current companies with reported revenue have a combined latest revenue of ₹4.6 Lakh; the largest is Willius Pharmaceuticals Private Limited at ₹4.4 Lakh (FY 2025).
Current companies
| Company | Designation | Appointment | Founded | Revenue | Status |
|---|---|---|---|---|---|
| Additional Director | 30 Mar 2023 | 2021 | ₹4.4 Lakh (FY 2025) | Active | |
| Additional Director | 31 Mar 2023 | 2021 | ₹20,469 (FY 2025) | Active |
Board colleagues of Mausam Sinha
| Name | DIN | Company | Designation |
|---|---|---|---|
| Dimpal Kumari Singh | 09020075 | Willius Pharmaceuticals Private Limited | Director |
| Nivedika Kumari | 09262565 | Biocius Pharmaceuticals Private Limited | Director |
Directorship timeline
Open interactive timeline →Shareholding and investment profile for Mausam Sinha
Company-level share counts, filed values, and quarterly changes require authenticated premium access.
- Company-level holdings
- Filed share counts
- Reported values
- Quarterly changes
Verified entity values are shown only after access is granted.
Frequently Asked Questions about Mausam Sinha
Mausam Sinha currently holds 2 directorships: Willius Pharmaceuticals Private Limited (Additional Director, since 30 Mar 2023, revenue ₹4.4 Lakh (FY 2025)); Biocius Pharmaceuticals Private Limited (Additional Director, since 31 Mar 2023, revenue ₹20,469 (FY 2025)).
Mausam Sinha was first appointed on 30 Mar 2023 as Additional Director at Willius Pharmaceuticals Private Limited.
The 2 current companies of Mausam Sinha that report revenue have a combined latest revenue of ₹4.6 Lakh: Willius Pharmaceuticals Private Limited ₹4.4 Lakh (FY 2025); Biocius Pharmaceuticals Private Limited ₹20,469 (FY 2025).
The current boards of Mausam Sinha's companies include Dimpal Kumari Singh (Willius Pharmaceuticals Private Limited), Nivedika Kumari (Biocius Pharmaceuticals Private Limited).